| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
10,218 |
9,154 |
$379K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
1,825 |
1,813 |
$144K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
1,712 |
1,707 |
$143K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
1,224 |
1,220 |
$111K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
1,445 |
1,424 |
$110K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
9,119 |
4,530 |
$97K |
| 87428 |
|
1,604 |
1,540 |
$89K |
| 99429 |
|
1,555 |
1,544 |
$51K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
1,536 |
1,523 |
$37K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
2,507 |
2,427 |
$34K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
2,174 |
2,159 |
$18K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
446 |
396 |
$18K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
814 |
408 |
$11K |
| 90461 |
|
2,737 |
2,370 |
$10K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
946 |
871 |
$9K |
| 92587 |
|
3,717 |
3,685 |
$8K |
| 99381 |
|
108 |
107 |
$7K |
| 0001A |
|
114 |
114 |
$4K |
| 0002A |
|
104 |
103 |
$4K |
| 0071A |
|
99 |
99 |
$4K |
| 0072A |
|
67 |
67 |
$3K |
| 99383 |
|
13 |
13 |
$1K |
| U0004 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r |
13 |
13 |
$975.00 |
| 0003A |
|
19 |
19 |
$760.00 |
| 90619 |
|
116 |
116 |
$167.53 |
| 90681 |
|
203 |
203 |
$0.00 |
| 90633 |
|
464 |
461 |
$0.00 |
| 90670 |
|
906 |
905 |
$0.00 |
| G9920 |
Screening performed and negative |
3,208 |
3,132 |
$0.00 |
| 90713 |
|
109 |
109 |
$0.00 |
| 90707 |
|
504 |
503 |
$0.00 |
| 99173 |
|
3,228 |
3,215 |
$0.00 |
| 90734 |
|
249 |
249 |
$0.00 |
| 90648 |
|
385 |
384 |
$0.00 |
| 90715 |
|
130 |
130 |
$0.00 |
| 90700 |
|
447 |
443 |
$0.00 |
| 91300 |
|
274 |
251 |
$0.00 |
| 90677 |
|
310 |
307 |
$0.00 |
| 90723 |
|
63 |
63 |
$0.00 |
| 90698 |
|
474 |
473 |
$0.00 |
| 90680 |
|
201 |
201 |
$0.00 |
| 90716 |
|
542 |
541 |
$0.00 |
| 90686 |
|
672 |
671 |
$0.00 |
| 90651 |
|
167 |
166 |
$0.00 |
| 91307 |
|
179 |
168 |
$0.00 |
| 90744 |
|
93 |
92 |
$0.00 |
| 96127 |
|
59 |
59 |
$0.00 |